Survival after cancer in Italian persons with aids, 1986-2005: A population-based estimation

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 4, 2014, Pages 428-435

  Maso, Luigino Dal ^a   Suligoi, Barbara ^b   Franceschi, Silvia ^c   Braga, Claudia ^a   Buzzoni, Carlotta ^d,e   Polesel, Jerry ^a   Zucchetto, Antonella ^a,f   Piselli, Pierluca ^g   Falcini, Fabio ^h   Caldarella, Adele ^e   Zanetti, Roberto ⁱ   Vercelli, Marina ^j   Guzzinati, Stefano ^k   Russo, Antonio ^l   Tagliabue, Giovanna ^m   Iachetta, Francesco ⁿ   Ferretti, Stefano ^o   Limina, Rosa M ^p   Mangone, Lucia ^h   Michiara, Maria ^q   Stracci, Fabrizio ^r   Pirino, Daniela R ^s   Piffer, Silvano ^t   Giacomin, Adriano ^u   Vitarelli, Susanna ^v   Mazzoleni, Guido ^w   Iannelli, Arturo ^x   Contrino, Maria L ^y   Fusco, Mario ^z   Tumino, Rosario ^aa   Fanetti, Anna C ^ab   De Paoli, Paolo ^ac   Decarli, Adriano ^f   Serraino, Diego ^a,ad   more..

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d AIRTUM Database   (Italy)

^e Tuscany Cancer Registry   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^h IRCCS   (Italy)

ⁱ Piedmont Cancer Registry   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^l Milan Cancer Registry   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^o UNIVERSITY OF FERRARA   (Italy)

^p Local Health Unit of Brescia   (Italy)

^q UNIVERSITY HOSPITAL OF PARMA   (Italy)

^r UNIVERSITY OF PERUGIA   (Italy)

^s Cancer Registry of Sassari   (Italy)

^t Registro Tumori della Provincia di Trento   (Italy)

^u Registro Tumori Piemonte   (Italy)

^v UNIVERSITY OF CAMERINO   (Italy)

^w Alto Adige Sudtirol Cancer Registry   (Italy)

^x Salerno Cancer Registry   (Italy)

^y ASP of Siracusa   (Italy)

^z ASL Napoli 3 SUD   (Italy)

^aa CIVILE M P AREZZO HOSPITAL   (Italy)

^ab Sondrio Cancer Registry   (Italy)

^ac Scientific Direction Italian National Research Center on Aging (INRCA)   (Italy)

^ad Friuli Venezia Giulia Cancer Registry   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANUS CANCER; ARTICLE; BRAIN CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN CANCER; STOMACH TUMOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ITALY; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SARCOMA, KAPOSI; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84903776698     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000184     Document Type: Article

References (50)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100B. A Review of human carcinogenesis. IARC Monogr Eval Carcinog Risks Hum. 2012;100(pt B):1-441
2. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299
3. Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51-59. (Pubitemid 351920404)
4. Serraino D, Zucchetto A, Suligoi B, et al. Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study. J Acquir Immune Defic Syndr. 2009;51:99-102
5. Harrison KMD, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr. 2010;53:124-130
6. Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS. 2010;24: 1537-1548
7. Helleberg M, Kronborg G, Larsen CS, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection. 2012;40:627-634
8. Serraino D, De Paoli A, Zucchetto A, et al. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol. 2010;34: 257-261
9. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV- 1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50: 1387-1396
10. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51:957-962
11. Marin B, Thiébaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23:1743-1753
12. Puhan MA, Van Natta ML, Palella FJ, et al. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. Clin Infect Dis. 2010;51:947-956
13. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalité 2000 and 2005" Survey (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590-598
14. Zucchetto A, Suligoi B, De Paoli A, et al. Excess mortality for non- AIDS-defining cancers among people with AIDS. Clin Infect Dis. 2010;51:1099-1101
15. Brau N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007;47:527-537. (Pubitemid 47334759)
16. Oehler-Jänne C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol. 2008;26:2550-2557
17. Norden AD, Drappatz J, Wen PY, et al. Survival among patients with primary central nervous system lymphoma, 1973-2004. J Neurooncol. 2011;101:487-493
18. Gramenzi A, Tedeschi S, Cantarini MC, et al. Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. Dig Liver Dis. 2013;45:516-522
19. Chao C, Xu L, Abrams D, et al. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010;24:1765-1770
20. Spagnuolo V, Travi G, Galli L, et al. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study. Cancer. 2013;119:2710-2719
21. Rengan R, Mitra N, Liao K, et al. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol. 2012;13:1203-1209
22. Gopal S, Patel MR, Yanik EL, et al. Temporal Trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst. 2013;105:1221-1229
23. Biggar RJ, Engels E, Ly S, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr. 2005;39:293-299. (Pubitemid 40923208)
24. Centro Operativo AIDS. Aggiornamento dei casi di AIDS notificati in Italia e delle nuove diagnosi di infezione da HIV. Dicembre 2007. Notiziario dell'Istituto Superiore di Sanità. 2008;21(suppl 1):3-23
25. Curado MP, Edwards B, Shin HR, et al, eds. Cancer Incidence in Five Continents, Vol. IX. Lyon: International Agency for Research on Cancer; 2007
26. Polesel J, Franceschi S, Suligoi B, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer. 2010;127:1437-1445
27. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer. 1998; 78:966-970. (Pubitemid 28430030)
28. AIRTUM Working Group. Italian cancer figures report. Survival of cancer patients in Italy. Epidemiol Prev. 2011;35(suppl 3):1-200. Available at: http://www.registri-tumori.it/cms/Rapp2011. Accessed May 30, 2014
29. Dal Maso L, Braga C, Franceschi S. Methodology used for "software for automated linkage in Italy" (SALI). J Biomed Inform. 2001;34:387-395. [Description of upgraded version of SALI software at http://www.registri-tumori. it/PDF/AIRTUM2009HANDBOOK/Chapter- Appendix2.pdf]
30. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97:425-432. (Pubitemid 40528605)
31. De Angelis R, Francisci S, Baili P, et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909-930
32. Rosso S, De Angelis R, Ciccolallo L, et al. Multiple tumours in survival estimates. Eur J Cancer. 2009;45:1080-1094
33. Dal Maso L. Legame tra l'immunodeficienza HIV-correlata e l'insorgenza di tumori: aspetti di metodologia statistica. Ph.D. Thesis. Milan University: Italy; 2012. Available at: http://air.unimi.it/bitstream/2434/168454/4/phd- unimi-R08222.pdf
34. Dal Maso L, Rezza G, Zambon P, et al. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer. 2001;93:430-435. (Pubitemid 32592064)
35. Dal Maso L, Polesel J, Ascoli V, et al. Cancer and AIDS registry linkage study. Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer. 2005; 92:188-193
36. Shiels M, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA. 2011;305: 1450-1459
37. Montlahuc C, Guiguet M, Abgrall S, et al. Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009). J Acquir Immune Defic Syndr. 2013;64:197-203
38. Sigel K, Crothers K, Dubrow R, et al. Prognosis in HIV-infected patients with non-small cell lung cancer. Br J Cancer. 2013;109:1974-1980
39. Acherbach CJ, Cole SR, Kitahara MM, et al. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS. 2011;25:691-700
40. Dal Maso L, Franceschi S, Lise M, et al. Self-reported history of Papsmears in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010;10:310
41. Pakkala S, Chen Z, Rimland D, et al. Human immunodeficiency virusassociated lung cancer in the era of highly active antiretroviral therapy. Cancer. 2012;118:164-1672
42. Suneja G, Shiels MS, Melville SK, et al. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS. 2013; 27:459-468
43. Montoto S, Shaw K, Okosun J, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30:4111-4116
44. Martis N, Mounier N. Hodgkin lymphoma in patients with HIV infection: a review. Curr Hematol Malig Rep. 2012;7:228-234
45. Silverberg MJ, Leyden W, Warton EM, et al. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105:350-360
46. Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients-Where do we stand today? Am J Transpl. 2008;8:2192-2198
47. Antiretroviral Therapy Cohort Collaboration. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis. 2009;48:1138-1151
48. Conti S, Farchi G, Galletti A, et al. La notifica della mortalità per AIDS in Italia (1992): qualità della certificazione e sottonotificata. Giornale Italiano Dell'AIDS. 1997;8:12-16
49. Kaldor JM, Delpech V, Guy RJ. AIDS case reporting: do we still need it? Lancet. 2008;373:181-183
50. Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol. 2008;26: 4834-4842